Investor's Business Daily
- Home
- WVE
as of 12-12-2025 3:57pm EST
$16.59
$0.18
-1.04%
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Chart Type:
Time Range:
| Founded: | 2012 | Country: | Singapore |
| Employees: | N/A | City: | SINGAPORE |
| Market Cap: | 1.2B | IPO Year: | 2015 |
| Target Price: | $27.53 | AVG Volume (30 days): | 12.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.74 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.28 - $21.73 | Next Earning Date: | 11-10-2025 |
| Revenue: | $109,230,000 | Revenue Growth: | 103.75% |
| Revenue Growth (this year): | -61.02% | Revenue Growth (next year): | 31.09% |
AI-Powered WVE Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 72.48%
72.48%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Wave Life Sciences Ltd. (WVE)
Moran Kyle
Sell
Chief Financial Officer
WVE Dec 9, 2025
Avg Cost/Share
$20.14
Shares
50,036
Total Value
$1,001,979.00
Owned After
90,365
HENRY CHRISTIAN O
Sell
Director
WVE Dec 8, 2025
Avg Cost/Share
$14.40
Shares
93,445
Total Value
$1,369,323.75
Owned After
12,700
Rawcliffe Adrian
Sell
Director
WVE Dec 8, 2025
Avg Cost/Share
$15.00
Shares
42,000
Total Value
$630,000.00
Owned After
12,700
SEC Form 4
Francis Chris
Sell
See Remarks
WVE Dec 8, 2025
Avg Cost/Share
$14.66
Shares
441,031
Total Value
$6,427,084.96
Owned After
25,000
Moran Kyle
Sell
Chief Financial Officer
WVE Dec 8, 2025
Avg Cost/Share
$14.85
Shares
210,000
Total Value
$3,102,000.00
Owned After
90,365
CORRIGAN MARK
Sell
Director
WVE Dec 8, 2025
Avg Cost/Share
$13.58
Shares
16,115
Total Value
$217,297.47
Owned After
28,815
Wagner Heidi L
Sell
Director
WVE Dec 8, 2025
Avg Cost/Share
$13.50
Shares
14,000
Total Value
$189,000.00
Owned After
44,930
Verdine Gregory L.
Sell
Director
WVE Dec 8, 2025
Avg Cost/Share
$13.57
Shares
20,000
Total Value
$269,460.80
Owned After
283,197
Tan Aik Na
Sell
Director
WVE Dec 8, 2025
Avg Cost/Share
$13.59
Shares
134,218
Total Value
$1,823,158.50
Owned After
25,400
RA CAPITAL MANAGEMENT, L.P.
Buy
Director, 10% Owner
WVE Nov 13, 2025
Avg Cost/Share
$6.69
Shares
1,000
Total Value
$6,687.50
Owned After
18,203,009
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Moran Kyle | WVE | Chief Financial Officer | Dec 9, 2025 | Sell | $20.14 | 50,036 | $1,001,979.00 | 90,365 | |
| HENRY CHRISTIAN O | WVE | Director | Dec 8, 2025 | Sell | $14.40 | 93,445 | $1,369,323.75 | 12,700 | |
| Rawcliffe Adrian | WVE | Director | Dec 8, 2025 | Sell | $15.00 | 42,000 | $630,000.00 | 12,700 | |
| Francis Chris | WVE | See Remarks | Dec 8, 2025 | Sell | $14.66 | 441,031 | $6,427,084.96 | 25,000 | |
| Moran Kyle | WVE | Chief Financial Officer | Dec 8, 2025 | Sell | $14.85 | 210,000 | $3,102,000.00 | 90,365 | |
| CORRIGAN MARK | WVE | Director | Dec 8, 2025 | Sell | $13.58 | 16,115 | $217,297.47 | 28,815 | |
| Wagner Heidi L | WVE | Director | Dec 8, 2025 | Sell | $13.50 | 14,000 | $189,000.00 | 44,930 | |
| Verdine Gregory L. | WVE | Director | Dec 8, 2025 | Sell | $13.57 | 20,000 | $269,460.80 | 283,197 | |
| Tan Aik Na | WVE | Director | Dec 8, 2025 | Sell | $13.59 | 134,218 | $1,823,158.50 | 25,400 | |
| RA CAPITAL MANAGEMENT, L.P. | WVE | Director, 10% Owner | Nov 13, 2025 | Buy | $6.69 | 1,000 | $6,687.50 | 18,203,009 |
Latest Wave Life Sciences Ltd. News
WVE Breaking Stock News: Dive into WVE Ticker-Specific Updates for Smart Investing
Compare WVE vs Leading Stocks
See how WVE stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "WVE Wave Life Sciences Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.